Research and development (R&D) is the lifeblood of innovation and advancements in medicine and science. As new technology, research avenues, and guidelines are introduced, it impacts how academic and corporate R&D teams in life sciences approach their work. In recent years, growing regulatory pressures and the pursuit of cost savings, shorter timelines, and enhanced outcomes

In the medical device industry, ensuring that products are sterile and remain so until use is a critical requirement. Packaging plays a crucial role in maintaining the sterility and integrity of medical devices. The interplay between packaging and sterilization is complex. As the industry moves away from ethylene oxide (“EtO”) to replacement modalities such as

Embracing Innovation Requires Intestinal Fortitude, an Understanding of History, and Measured Patience Every week, if not every day, you can find a headline claiming that the sky is falling because of pending restrictions on ethylene oxide (EtO) sterilization. Depending on what side of the issue you are on, it is either “you will die because

NovaSterilis, a pioneer in medical device sterilization using supercritical carbon dioxide (“scCO2”), has been awarded a $1.75 million SBIR (Small Business Innovation Research) Phase II grant by the NIAID (National Institute of Allergy and Infectious Diseases). This funding furthers the development of NovaSterilis’ scCO2 terminal sterilization platform for the pharmaceutical and biotechnology industries. This effort will

As decision-makers in the medical device and therapeutics industries, why do we do what we do? Sure, we want to make money and to some degree, stroke our ego. More likely, our primary driver is that we are wired to help our fellow humans.  Our vision is straightforward – we want to improve people’s lives by

NovaSterilis, a leading innovator in medical device sterilization using supercritical carbon dioxide ("scCO2"), announces a collaboration with Dr. Jason Spector, M.D., Professor of Surgery and Chief of the Division of Plastic and Reconstructive Surgery at Weill Cornell Medicine, through New York State's Center for Advanced Technology (CAT) grant program. NovaSterilis and Dr. Spector's research group will embark on an important regenerative medicine research initiative.

Sterility Assurance Level is typically an afterthought but can significantly impact product development schedules. Integrating sterilization strategies early on is vital for ensuring successful and timely introductions. In this article, Tony Eisenhut, CEO of NovaSterilis emphasizes the importance of considering sterilization in the early stages of R&D for new medical devices or therapeutics. Exploring Alternatives for Effective

Ethylene oxide sterilization is a broadly used method within the industrial and healthcare industries for sterilizing a wide range of products. However, its potential environmental and health effects have raised concerns among advocacy groups and government agencies. In this article, Tony Eisenhut, CEO of NovaSterilis, stresses the importance of finding better alternatives to EtO sterilization.

Supercritical CO2 (scCO2) sterilization is a safe and highly efficient method for sterilization with many applications in the MedTech industry. While ethylene oxide (EtO) has long been the leading industrial sterilization modality, its emissions have raised concerns regarding its impact on human health and the environment. In this context, scCO2 has emerged as a promising